2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kwon TK and Kim JC | In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl beta-cyclodextrin/minoxidil complex. | 2010 | Int J Pharm | pmid:20362653 |
| Boyd BJ et al. | A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. | 2007 | Int J Pharm | pmid:17467935 |
| Réeff J et al. | Characterization and optimization of GMO-based gels with long term release for intraarticular administration. | 2013 | Int J Pharm | pmid:23651644 |
| Gonçalves VSS et al. | Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs. | 2016 | Int J Pharm | pmid:27702697 |
| Sadhale Y and Shah JC | Biological activity of insulin in GMO gels and the effect of agitation. | 1999 | Int J Pharm | pmid:10556741 |
| Lee J and Kellaway IW | Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-ala2, D-leu5]enkephalin from a cubic phase of glyceryl monooleate. | 2000 | Int J Pharm | pmid:11011997 |
| Lee J and Kellaway IW | In vitro peptide release from liquid crystalline buccal delivery systems. | 2000 | Int J Pharm | pmid:10675679 |
| Sintov AC | Transdermal delivery of curcumin via microemulsion. | 2015 | Int J Pharm | pmid:25655717 |
| Zhang Y et al. | Transdermal baicalin delivery using diethylene glycol monoethyl ether-mediated cubic phase gel. | 2015 | Int J Pharm | pmid:25543112 |
| Liu Y et al. | Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. | 2011 | Int J Pharm | pmid:21540088 |